BACE1 and early-onset autosomal dominant Alzheimer disease: In fact, the miR-124 level in the brain of patients with Alzheimer’s disease is down-regulated, in parallel to the increase in expression of beta-site expression APP-cleaving enzyme 1 (BACE1) [33].